MedTrace Logo

Reversal of Right Ventricular Steatosis in Pulmonary Hypertension

NCT02966899 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-12-13

No results posted yet for this study

Summary

The goal of this study is to elucidate the relationship between myocardial right ventricular triglyceride content (steatosis) and right ventricular dysfunction in participants with pulmonary hypertension, and investigate reversibility of this phenotype with omega-3 fatty acid treatment.

Conditions

  • Pulmonary; Hypertension
  • Steatosis
  • Right Ventricular Failure

Interventions

DIETARY_SUPPLEMENT

Omega-3 fatty acids

Sponsors & Collaborators

  • Wen-Chih Wu

    lead FED

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02966899 on ClinicalTrials.gov